Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1

Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation

Authors Borges V, Simon A, Senna A, Cabral L, de Sousa V

Received 20 October 2012

Accepted for publication 6 December 2012

Published 9 February 2013 Volume 2013:8(1) Pages 535—544

DOI https://doi.org/10.2147/IJN.S39383

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Vinícius Raphael de Almeida Borges, Alice Simon, Adrian Ricardo Cuello Sena, Lúcio Mendes Cabral, Valéria Pereira de Sousa

Department of Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Background: Topical administration of dapsone can be an alternative route for treatment of leprosy and can also provide new therapeutic applications for an established drug. However, the physicochemical properties of dapsone make it difficult to incorporate into conventional formulations. The current study was directed toward developing a stable nanoemulsion that contains dapsone which can be adapted for topical use.
Methods: Nanoemulsions were prepared using isopropyl myristate or n-methyl-pyrrolidone as the oil phase, and characterized according to their mean droplet size, conductivity, refractive index, pH, drug content, and stability. The in vitro release of dapsone and its ability to permeate the epidermis were also evaluated.
Results: Physicochemical characterization demonstrated that nanosystems were formed, which had a uniform droplet distribution and a pH compatible with the skin surface. Use of n-methyl-pyrrolidone provided a greater nanoemulsion region and higher solubilization of dapsone, and increased the in vitro release rate when compared with a nanoemulsion prepared using isopropyl myristate. However, use of isopropyl myristate promoted an increase in in vitro epidermal permeation that followed the Higuchi model. This demonstrates the ability of a nanosystem to influence permeation of dapsone through the skin barrier. Furthermore, the nanoemulsions developed and evaluated here had ideal physicochemical stability over a 3-month period.
Conclusion: Incorporation of dapsone into a nanoemulsion may be a promising system for enabling topical delivery of dapsone, while minimizing skin permeation, for the treatment of acne. The method developed here used isopropyl myristate as the oil phase, and promoted permeation of dapsone through the skin barrier for the treatment of leprosy upon use of n-methyl-pyrrolidone as the oil phase.

Keywords: dapsone, nanoemulsion, topical, release, permeation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Nanostructured systems containing babassu (Orbignya speciosa) oil as a potential alternative therapy for benign prostatic hyperplasia

de Sousa VP, Crean J, Borges VRA, Rodrigues CR, Tajber L, Boylan F, Cabral LM

International Journal of Nanomedicine 2013, 8:3129-3139

Published Date: 15 August 2013

Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studies

Monteiro LM, Lione VF, do Carmo FA, do Amaral LH, da Silva JH, Nasciutti LE, Rodrigues CR, Castro HC, de Sousa VP, Cabral LM

International Journal of Nanomedicine 2012, 7:5175-5182

Published Date: 28 September 2012

Preparation and evaluation of antimicrobial activity of nanosystems for the control of oral pathogens Streptococcus mutans and Candida albicans

Pupe CG, Villardi M, Rodrigues CR, Rocha HVA, Maia LC, de Sousa VP, Cabral LM

International Journal of Nanomedicine 2011, 6:2581-2590

Published Date: 26 October 2011

Preparation and evaluation of lidocaine hydrochloride in cyclodextrin inclusion complexes for development of stable gel in association with chlorhexidine gluconate for urogenital use

Soares da Silva LFJ, Carmo FA, Borges VRA, Monteiro LM, Rodrigues CR, Cabral LM, Sousa VP

International Journal of Nanomedicine 2011, 6:1143-1154

Published Date: 3 June 2011